Advertisement

Breast cancer and its impact in male transsexuals

  • Dejan Nikolić
  • Miroslav Granić
  • Nebojša Ivanović
  • Darko Zdravković
  • Aleksandra Nikolić
  • Violeta Stanimirović
  • Marija Zdravković
  • Srdjan Dikić
  • Marko Nikolić
  • Miroslav Djordjević
Review

Abstract

Introduction

Lesbian, gay, and bisexuals have unique healthcare needs. Breast cancer is leading cancer in women, worldwide, accounting for 25% of all cases. Annual incidence rates increased significantly in all countries and age groups. The occurrence of breast cancer is rare in transgender population. As they have very limited access to medical care, it is much less likely to pursue breast cancer screening than in other individuals not identified as transgender.

Review of the cases from literature

Up to date, only 13 cases of the breast cancer transsexuals (female to male) have been reported in six published papers worldwide. Histological examination of the breast tumor in female-to-male transgender showed progesterone/estrogen-positive invasive ductal carcinoma.

Discussion

Gender identity describes a person’s inherent sense of being a woman, man, or of neither gender, whereas sexual orientation refers to how people identify their physical and emotional attraction to others. Gender reassignment surgery, as series of complex surgical genital and non-genital procedures, is recognized as the most effective treatment for patients with gender dysphoria. The two main principles of hormone therapy for transgender patients are to reduce endogenous hormone levels and their associated sex characteristics and replace them with hormones of the preferred sex. Breast cancer infrequently occurs in transgender patients. Even breast core biopsies can be difficult for interpreting after changes in breast tissue in female-to-male transsexuals following gender reassignment.

Conclusion

Reviewing the literature, so many different data concerning probability of breast cancer in sexual minority can be found. Breast cancer screening program should be offered to all transgender individuals according to national guidelines. Very important is to take into consideration a transgender person’s natal and surgical anatomy, unique clinical concerns for depression and anxiety, risk of suicide together with risk factors including experiences of harassment or physical or sexual violence, low education level, and unemployment. Understanding the need for mammography in these often marginalized groups is very important in addressing breast cancer disparities despite differences in insurance coverage in some countries and greater concern for the cancer of the breast in residual breast tissue. The best screening rule, ever, for breast cancer in male transsexuals and other similar population should be, besides surgical history and hormonal status, “Screen Now, Screen Regularly and Screen What You Have.”

Keywords

Breast cancer Transsexualism Screening Mammography 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this type of study formal consent is not required.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    McNamara M, et NG H (2016) Best practices in LGBT care: A guide for primary care physicians. Clev Clin J Med 83(7):533–540CrossRefGoogle Scholar
  2. 2.
    ”World Cancer Report” (2014) World Health Organization. 2014. pp. Chapter 1.1. ISBN 92-832-0429-8Google Scholar
  3. 3.
    Nikolic DV, Djordjevic ML, Granic M, Nikolic AT, Stanimirovic VV, Zdravkovic D, Jelic S (2012) Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy. World J Surg Oncol 10:280CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    World Cancer Report (2008) International Agency for Research on CancerGoogle Scholar
  5. 5.
    Male Breast Cancer Treatment (2014) National Cancer InstituteGoogle Scholar
  6. 6.
    Dimitrova N, Znaor A, Agius D, Eser S, Sekerija M, Ryzhov A, Primic-Žakelj M, Coebergh JW, SEE + Working Group (2017) Breast cancer in South-Eastern European countries since 2000. Rising incidence and decreasing mortality at young and middle ages. Eur J Cancer 83:43–55Google Scholar
  7. 7.
    Willemsen HW, Kaas R, Peterse JH, Rutgers EJ (1998) Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy. Eur J Surg Oncol 24(4):331–332CrossRefPubMedGoogle Scholar
  8. 8.
    Gooren LJ (2014) Management of female-to-male transgender persons: medical and surgical management, life expectancy. Curr Opin Endocrinol Diabetes Obes 21(3):233–238CrossRefPubMedGoogle Scholar
  9. 9.
    Ramos Boyero M (2008) Skin-sparing mastectomy: an alternative to conventional mastectomy in breast cancer. Cir Esp 84(4):181–187CrossRefPubMedGoogle Scholar
  10. 10.
    Katayama Y, Motoki T, Watanabe S, et al (2015) A very rare case of breast cancer in a female-to-male transsexual. Breast Cancer.  https://doi.org/10.1007/s12282-015-0661-4 PubMedGoogle Scholar
  11. 11.
    Pivo S, Montes J, Schwartz S, Chun J, Kiely D, Hazen A, Schnabel F (2017) Breast cancer risk assessment and screening in transgender patients. Clin Breast Cancer 17(5): e225–e227CrossRefPubMedGoogle Scholar
  12. 12.
    Burcombe RJ, Makris A, Pirtam M et al (2003) Breast cancer after bilateral subcutaneous mastectomy in female to male case. Breast 12:290–293CrossRefPubMedGoogle Scholar
  13. 13.
    Bevers TB (2010) Breast cancer prevention. an update of the STAR trial. Curr Treat Options Oncol 11:66–69CrossRefPubMedGoogle Scholar
  14. 14.
    Brown GR, Jones KT. Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Res Treat 149(1):191–198Google Scholar
  15. 15.
    Bazzi AR, Whorms DS, King DS et al (2015) Adherence to mammography screening guidelines among transgender persons and sexual minority women. Am J Public Health 105:2356–2358CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Burcombe RJ, Makris A, Pittam M, Finer N (2003) Breast cancer after bilateral subcutaneous mastectomy in a female to male transsexual. Breast 12(4):290–293CrossRefPubMedGoogle Scholar
  17. 17.
    Shao T, Grossbard LM, Klein P (2011) Breast cancer in Female to male transsexuals: two cases with a review of physiology and management. Clin Breast Cancer 11(6):417–419CrossRefPubMedGoogle Scholar
  18. 18.
    Gooren LJ, van Trotsenburg MA, van Diest GiltayEj (2013) PJ.: Breast cancer development in transsexual subjects receiving cross-sex hormone treatment. J Sex Med 10(12):3129–3134CrossRefPubMedGoogle Scholar
  19. 19.
    Kotsopoulos J, Steve A (2017) Androgens and breast cancer. J Sex Med 14(5):741–746CrossRefGoogle Scholar
  20. 20.
    Spack NP (2013) Management of transgenderism. JAMA 309:474–484Google Scholar
  21. 21.
    National LGBT Health Education Center (2016) Achieving health equity for lesbian, gay, bisexual, and transgender (LGBT) people, Module 1. http://www.lgbthealtheducation.org/wp- content/uploads/Achieving-Health-Equity-for-LGBT-People-1.pdf. Accessed May 19, 2016
  22. 22.
    Selvaggi G, Bellringer J (2011) Gender reassignment surgery: an overview. Nat Rev Urol 8(5):274–282CrossRefPubMedGoogle Scholar
  23. 23.
    Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA et al (2009) Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94:3132–3133CrossRefPubMedGoogle Scholar
  24. 24.
    Teoh ZT, Archampong D, Gate T (2015) Breast cancer in male to female (MtF) transgender patients:isformonereceptore negativity a feature? BMJ Case Rep.  https://doi.org/10.1136/brc-2015-209396 Google Scholar
  25. 25.
    Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. New Engl J Med 354:270–282CrossRefPubMedGoogle Scholar
  26. 26.
    Secreto G, Zumoff B (2012) Role of androgen excess in the development of estrogen receptor-positive and estrogen receptor-negative breast cancer. Anticancer Res 32:3223–3228PubMedGoogle Scholar
  27. 27.
    Hankinson SE et al (1998) Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90(17):1292–1299CrossRefPubMedGoogle Scholar
  28. 28.
    Veronesi U, Pizzocaro G (1968) Breast cancer in women subsequent to cystic disease of the breast. Surg Gynecol Obstet 126(3):529–532PubMedGoogle Scholar
  29. 29.
    Secreto G et al (1984) Increased androgenic activity and breast cancer risk in premenopausal women. Cancer Res 44(12 Pt 1):5902–5905PubMedGoogle Scholar
  30. 30.
    James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjonneland A et al (2011) Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study. Cancer Prev Res 4:1626–1635CrossRefGoogle Scholar
  31. 31.
    Diaz-Chico N, German Rodriguez B, Gonazalez F, Ramirez A, Bilbao R, Cabrera de Lekon C, et al (2007) Androgens and androgen receptors in breast cancer. J Steroid Bichem Mol Biol 105:1–15CrossRefGoogle Scholar
  32. 32.
    Adly L, Hill D, Sherman ME, Sturgeon SR, Fears T, Mies C et al (2006) Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women. Int J Cancer 119:2702–2707CrossRefGoogle Scholar
  33. 33.
    Danforth KN, Eliassen AH, Tworoger SS, Missmer SA, Barbieri PL, Rosner BA et al (2010) The association of plasma androgen levels with breast, ovarian and endometrial cancer risk among postmenopausal women. Int J Cancer 126:199–207CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Mathwe H, Hamid B (2013) Context is everything:an unusual breast core biopsy case. Int J Surg Pathol 21(5):502–503CrossRefGoogle Scholar
  35. 35.
    Hartmann LC et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New Engl J Med 340(2):77–84CrossRefPubMedGoogle Scholar
  36. 36.
    Meads C, Moore D (2013) Breast cancer in lesbians and bisexual women: systematic review of incidence, prevalence and risk studies. BMC Public health 13:1127CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Mays VM, Cochran SD (2001) Mental health correlates of perceived discrimination among lesbian, gay, and bisexual adults in the United States. Am J Public Health 91:1869–1875CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Center of Excellence for Transgender Health (2011) Primary care protocol for transgender patient care. Department of Family and Community Medicine, University of California, San FranciscoGoogle Scholar
  39. 39.
    Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA et al (2009) Endocrine treatment of trnassexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94(9):3132–3154CrossRefPubMedGoogle Scholar
  40. 40.
    Sherbourne Health Center (2009) Guidelines and protocols for comprehensive primary care for trans clients. Sherbourne Health Center, TorontoGoogle Scholar
  41. 41.
    Eldar S, Meguid MM, Beatty JD (1984) Cancer of the breast after prophylactic subcutaneous mastectomy. Am J Surg 148(5):692–693CrossRefPubMedGoogle Scholar
  42. 42.
    Goodnight JE, Quagliana JM, Morton DL (1984) Failure of subcutaneous mastectomy to prevent the development of breast cancer. J SurgOncol 26(3):198–201Google Scholar
  43. 43.
    Ziegler LD, Kroll SS (1991) Primary breast cancer after prophylactic mastectomy [clinical conference]. Am J Clin Oncol 14(5):451–454PubMedGoogle Scholar
  44. 44.
    Bowers DG, Radlauer CB (1969) Breast cancer after prophylactic subcutaneous mastectomies and reconstruction with silastic prostheses. Plast Reconstr Surg 44(6):541–544CrossRefPubMedGoogle Scholar
  45. 45.
    Holleb AI, Montgomery R, Farrow JH (1965) The hazard of incomplete simple mastectomy. SurgGynecol Obstet 121(4):819–822Google Scholar
  46. 46.
    Robertson Bazzi A, Whorms SD, King SD, Potter J (2015) Adherence to mamography screening guidelines among transgender persons and sexual minorities. Am J Public Health 105(11):2356–2358CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Dejan Nikolić
    • 1
    • 2
  • Miroslav Granić
    • 1
    • 2
  • Nebojša Ivanović
    • 1
    • 2
  • Darko Zdravković
    • 1
    • 2
  • Aleksandra Nikolić
    • 1
    • 3
  • Violeta Stanimirović
    • 4
  • Marija Zdravković
    • 1
    • 2
  • Srdjan Dikić
    • 1
    • 2
  • Marko Nikolić
    • 1
  • Miroslav Djordjević
    • 1
    • 5
  1. 1.Faculty of MedicineUniversity of BelgradeBelgradeSerbia
  2. 2.University Medical Center Bežanijska kosaBelgradeSerbia
  3. 3.Institute for Cardiovascular Diseases DedinjeBelgradeSerbia
  4. 4.Medicine and Medical Devices Agency of Republic of SerbiaBelgradeSerbia
  5. 5.Children’s HospitalBelgradeSerbia

Personalised recommendations